isothiuronium has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fung, ML; Lau, TY; Leung, TM; Liong, EC; Nanji, AA; Tipoe, GL | 1 |
| Koike, M; Kominami, E; Nakanishi, H; Nishioku, T; Okamoto, Y; Peters, C; Saftig, P; Uchiyama, Y; von Figura, K; Yamamoto, K; Zhang, J | 1 |
2 other study(ies) available for isothiuronium and Disease Exacerbation
| Article | Year |
|---|---|
Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis.
Topics: Alanine Transaminase; Animals; Arginine; Blotting, Western; Carbon Tetrachloride; Chronic Disease; Disease Progression; Electrophoretic Mobility Shift Assay; Isothiuronium; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred ICR; Models, Animal; NF-kappa B; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Procollagen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factor AP-1; Transforming Growth Factor beta1 | 2008 |
Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice.
Topics: Animals; Apoptosis; Body Weight; Cathepsin D; Cell Count; Disease Progression; Drug Administration Schedule; Enzyme Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Intestine, Small; Isothiuronium; Macrophages; Mice; Mice, Knockout; Microglia; Neuronal Ceroid-Lipofuscinoses; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phagocytosis; Thalamus | 2001 |